The GPCRact AI model goes beyond AlphaFold3 by predicting whether drugs functionally activate G-protein-coupled receptors through allosteric signaling.
Phase I results demonstrate favorable safety, sustained target engagement, and early signs of anti-tumor activity -- Reinforce EP4 receptor antagonism as a validated, high-value strategy to overcome ...
Absci (NASDAQ:ABSI) used a presentation at the Leerink Partners Global Healthcare Conference to outline how the company is ...
Executives from Crinetics Pharmaceuticals (NASDAQ:CRNX) used an investor discussion at TD Cowen’s 46th Annual Healthcare Conference to highlight early U.S. commercial progress for its newly launched ...
In sum, the nonapeptide Oxytocin presents as a structurally well-defined peptide with a receptor system that is widely ...
Cone snails deploy sophisticated venom cocktails to paralyse prey. Anthony King talks to the researchers harnessing these peptides to develop new pain medications ...
It’s a mistake you hopefully only make once. What makes your clean, minty mouth taste so gross when it meets OJ?
The global weight-loss drug market is entering a new phase, driven by the arrival of oral options, looming generic rivals and falling U.S. prices for blockbuster treatments from Eli Lilly and Novo ...
编者按代谢相关脂肪性肝病(MASLD)及其更严重的炎症形式——代谢相关脂肪性肝炎(MASH),已成为全球性的重大健康挑战。然而,针对此病的有效药物治疗手段仍然有限。G蛋白偶联受体75(GPR75)是GPCR家族中的一个孤儿受体。此前的人类遗传学研究表明,GPR75的功能缺失变异与较低的体脂率和身体质量指数(BMI)相关。在动物 ...
Daridorexant is approved and marketed in Japan as QUVIVIQ® under a commercialization agreement between Nxera and Shionogi. QUVIVIQ®, discovered by Idorsia Pharmaceuticals, is marketed by Idorsia in ...
Detailed price information for Tectonic Therapeutic Inc (TECX-Q) from The Globe and Mail including charting and trades.
TD Cowen 46th Annual Health Care Conference March 4, 2026 9:50 AM ESTCompany ParticipantsMartin Hogan - Senior Director ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果